Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial
about
Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reductionStatins for acute coronary syndromeDyslipidemia and its therapeutic challenges in renal transplantationStatins: definitive translational researchRole of colesevelam in combination lipid-lowering therapyNon-cardiovascular effects associated with statinsThe therapeutic role of niacin in dyslipidemia managementEffect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trialsAdherence to drug label recommendations for avoiding drug interactions causing statin-induced myopathy--a nationwide register studyLack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapyEfficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trialsPerspectives and opportunities for nanomedicine in the management of atherosclerosis.The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trialsAlgorithms to Identify Statin Intolerance in Medicare Administrative Claim Data.Safety and efficacy of colesevelam HCl in the treatment of elderly patientsPrevalence of high-risk cardiovascular patients with therapy-resistant hypercholesterolemiaHigher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases.A method to identify and validate mitochondrial modulators using mammalian cells and the worm C. elegans.Statin-ezetimibe versus statin lipid-lowering therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventionHigh-potency statins and acute kidney injury-associated hospitalizations.Safety of statins: an updateSigmoidal maximal effect modeling of low-density lipoprotein cholesterol concentration and annual incidence of coronary heart disease events in secondary prevention trials.Statins and myocardial remodelling: cell and molecular pathways.Use of administrative data to estimate the incidence of statin-related rhabdomyolysis.The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.Statin drug interactions and related adverse reactions.Musculoskeletal safety outcomes of patients receiving daptomycin with HMG-CoA reductase inhibitors.Break the fast? Update on patient preparation for cholesterol testing.What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice.Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients: a meta-analysis.Mechanisms and assessment of statin-related muscular adverse effects.The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.Patterns and predictors of intensive statin therapy among patients with diabetes mellitus after acute myocardial infarction.The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome.Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trialSitagliptin/Simvastatin: a first combination tablet to treat type 2 diabetes and hypercholesterolemia--a review of its characteristicsStatin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.The efficacy and cost-effectiveness of statins in low-risk patients.From a fish tank injury to hospital haemodialysis: the serious consequences of drug interactions.National Assessment of Statin Therapy in Patients Hospitalized with Acute Myocardial Infarction: Insight from China PEACE-Retrospective AMI Study, 2001, 2006, 2011
P2860
Q21246041-211D72E1-FF93-47D2-B544-7625FFF60F37Q24193862-F2BCC1A6-F19F-4C47-BC80-0EE3DEA28A76Q26851294-709440DB-3388-408D-9E20-B1C1E500401DQ26851528-40A3C28F-8E2F-4E69-B203-538C6102D22CQ27016027-35C19026-6C61-4DDD-A8EF-37157B126E16Q27026332-87134006-06B3-4743-AB38-FB23C3A05BC0Q28304559-220799A5-A2DF-444B-BBC3-7BA64809653EQ28483807-837AB991-EE08-49B8-9DC5-B0335FE2DE10Q28535157-EFBF7DF3-86EE-4413-850C-36334B372DC6Q28732707-22569686-3052-4C81-8AA2-8FB184C92C82Q29617910-7C784BFB-C63A-4073-9E72-A95C90B9C536Q30455490-2A2CB7B7-21C8-4D7A-9B17-F0B9818E56B4Q30914775-D228F602-9401-4A57-AF28-0E8A3FC5989BQ31113251-368E4320-F668-433A-B19E-99DFCED0FD8BQ33663484-2202C241-3DBA-4DAF-8E22-0467362416C7Q33669805-1DE41B8D-285C-47BB-9676-6A5A16AE927CQ33685412-5592BF00-B092-44EF-A4EB-326F9CEC5BC7Q33749557-672B7A48-BD59-492E-9639-4F297C703662Q33780134-D91658A1-F465-4A7C-8A3B-F92281C5C5E8Q33877580-8B62F292-9483-422F-8FE6-854AD26D58B4Q33949312-3142AA76-D85D-4ADB-A672-DEFE9EA35007Q34041102-03867DE3-4CCA-4E43-BFA0-A16317DF78FBQ34196628-B1233090-9C6A-4E1A-9225-9C3D47232077Q34236480-F3442571-807A-472B-B6DC-A8AE343A937FQ34274829-B841DFDF-2987-4A05-8D3F-E4F0BB486B01Q34292468-E7607C5C-C673-4B92-A527-77C1B5EC5343Q34298999-9BD30B63-83A4-4A4C-A934-F2014FCB0930Q34337743-5A0EA415-EDD8-452C-8878-6591E40AA189Q34409791-83B4CE79-6583-426F-8D1E-22F8B242493AQ34456192-5734C98A-050F-46FD-A455-E6203C35F435Q34570995-9E86C57D-A131-43BC-9327-1ACB28E2DB86Q34630074-D872C5B6-855E-4319-89D2-407BBD106668Q34764244-1157F722-5F37-465A-BFEE-557828CC2746Q35021842-E2BB09D5-C4C7-449A-B486-6D084F84E27DQ35063739-F9AF1938-DAAA-4299-8C29-722409A2E152Q35100483-59C27E80-0905-43B6-B937-17F1D50EC20FQ35232279-27BE4774-8CE5-4FC4-81F2-CCE6BBC7EC35Q35551124-009DBB62-4579-4E28-8495-81363EAC7067Q35779291-84DBE024-FC5F-4524-BD71-25910139E0DEQ35983833-51DE0723-A9C4-4FB9-8C11-56A9616BC924
P2860
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Intensive lowering of LDL chol ...... double-blind randomised trial
@ast
Intensive lowering of LDL chol ...... double-blind randomised trial
@en
Intensive lowering of LDL chol ...... double-blind randomised trial
@nl
type
label
Intensive lowering of LDL chol ...... double-blind randomised trial
@ast
Intensive lowering of LDL chol ...... double-blind randomised trial
@en
Intensive lowering of LDL chol ...... double-blind randomised trial
@nl
prefLabel
Intensive lowering of LDL chol ...... double-blind randomised trial
@ast
Intensive lowering of LDL chol ...... double-blind randomised trial
@en
Intensive lowering of LDL chol ...... double-blind randomised trial
@nl
P2093
P2860
P50
P3181
P1433
P1476
Intensive lowering of LDL chol ...... double-blind randomised trial
@en
P2093
Jane Armitage
Kazem Rahimi
Louise Bowman
Richard Bulbulia
Richard Haynes
Richard Peto
P2860
P304
P3181
P356
10.1016/S0140-6736(10)60310-8
P407
P577
2010-11-13T00:00:00Z